DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1384]
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
SUMMARY: Veranova, L.P., has applied to be registered as a bulk manufacturer of basic
class(es) of controlled substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es), and applicants
therefore, may submit electronic comments on or objections to the issuance of the proposed
registration on or before [INSERT DATE 60 DAYS AFTER DATE OF PUBLICATION IN
THE FEDERAL REGISTER]. Such persons may also file a written request for a hearing on
the application on or before [INSERT DATE 60 DAYS AFTER DATE OF PUBLICATION
IN THE FEDERAL REGISTER].
ADDRESSES: The Drug Enforcement Administration requires that all comments be
submitted electronically through the Federal eRulemaking Portal, which provides the ability
to type short comments directly into the comment field on the Web page or attach a file for
lengthier comments. Please go to https://www.regulations.gov and follow the online
instructions at that site for submitting comments. Upon submission of your comment, you
will receive a Comment Tracking Number. Please be aware that submitted comments are not
instantaneously available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully submitted and
there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is
notice that on May 9, 2024, Veranova, L.P., 25 Patton Road, Pharmaceutical Service,

Devens, Massachusetts 01434-3803, applied to be registered as a bulk manufacturer of the
following basic class(es) of controlled substance(s):
Controlled Substance
Amphetamine
Methylphenidate
Nabilone
Hydrocodone
Levorphanol
Thebaine
Alfentanil
Remifentanil
Sufentanil

Drug Code
1100
1724
7379
9193
9220
9333
9737
9739
Schedule
II
II
II
II
II
II
II
II
II

The company plans to bulk manufacture the listed controlled substances in order to
support the manufacturing and analytical testing activities at its other Drug Enforcement
Administration-registered manufacturing facility. No other activities for these drug codes are
authorized for this registration.

Matthew J. Strait,
Acting Deputy Assistant Administrator.

[FR Doc. 2024-12576 Filed: 6/6/2024 8:45 am; Publication Date: 6/7/2024]